Biggest News Aggregation in the World
📰 Epimeron Inc News

Epimeron Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Epimeron Inc. Real-time updates on events, politics, business and more.

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN)

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment. 
Los Angeles United States University Of California San Francisco Stanford University Florida State University United Kingdom

Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives

Published: May 24, 2021 With this acquisition, Enveric will expand and complement its pipeline of naturally occurring cannabinoid compounds with a robust portfolio of psychedelic-derived molecules Enveric aims to move into the clinic with novel cannabinoid and psychedelic-derived therapies to improve standard of care and serve unmet needs across multiple indications including oncology and CNS, such as PTSD Upon closing, Dr. Joseph Tucker will be appointed Enveric Biosciences CEO and David J...
United Kingdom Caitlin Kasunich Raquel Cona David Johnson Valter Pinto Allison Soss Enveric Biosciences Joseph Tucker

Enveric Biosciences : Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives

  Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that it has entered into a definitive agreement to acquire MagicMed Industries Inc. ("MagicMed"), a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivati...
United Kingdom Caitlin Kasunich Raquel Cona David Johnson Valter Pinto Allison Soss Joseph Tucker Enveric Biosciences

Enveric Biosciences Inc. enters definitive agreement for an all-stock transaction to acquire MagicMed Industries Inc

Enveric Biosciences enters definitive agreement for an all-stock transaction to acquire MagicMed Industries Once closing is complete, Magic Med CEO Dr Joseph Tucker will be appointed chief executive officer of the enlarged company and David Johnson, chairman and CEO of Enveric will be appointed executive chairman The acquisition of MagicMed will expand and complement Enveric’s current pipeline of naturally occurring compounds, which is primarily focused on cannabinoids, to now inc...
United Kingdom David Johnson Joseph Tucker Epimeron Inc International Dial Magicmed Industries

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

MagicMed Industries Investor Overview

Accredited Investor email list Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above. By completing this form, you are giving consent to receive communication from MagicMed Industries using the contact information you provide. And remember you ca...
Peter Facchini Magicmed Psybrary Jillian Hagel Joseph Tucker Magicmed Industrie Management Team Department Of Biological Sciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science